[Corrigendum] Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis

Holmsten,Karin; Hammer Dohn,Line; Jensen,Niels  Viggo; Shah,Carl‑Henrik; Jäderling,Fredrik; Pappot,Helle; Ullén,Anders

doi:10.3892/ol.2017.6082

June-2017 Volume 13 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

June-2017 Volume 13 Issue 6

Full Size Image

Correction Open Access

[Corrigendum] Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis

Authors:
- Karin Holmsten
- Line Hammer Dohn
- Niels Viggo Jensen
- Carl‑Henrik Shah
- Fredrik Jäderling
- Helle Pappot
- Anders Ullén
View Affiliations / Copyright

Affiliations: Department of Oncology and Pathology, Karolinska University Hospital, SE‑171 76 Stockholm, Sweden, Department of Oncology, Rigshospitalet, 2100 Copenhagen, Denmark, Department of Oncology, Odense University Hospital, 5000 Odense, Denmark, Department of Radiology, Karolinska University Hospital, SE‑171 76 Stockholm, Sweden

Copyright: © Holmsten et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Pages: 5035-5035
|
Published online on: April 24, 2017

https://doi.org/10.3892/ol.2017.6082
Expand metrics +

Article

Oncol Lett 12: [Related article:] 1293-1300, 2016; DOI: 10.3892/ol.2016.4775

Following the publication of this article, an interested reader drew to our attention that, on p. 1,298, the two curves in Fig. 2A and B show identical data. The Kaplan-Meier curves in Fig. 2, as published, both show the data for the median overall survival (mOS) curve, and not the mOS and median progression-free survival (mPFS) curves. Fig. 2A was intended to have shown the Kaplan-Meier curve for mPFS, and Fig. 2B the curve for mOS.

Figure 2.

Survival data for patients with metastatic urothelial carcinoma treated with vinflunine as second-line chemotherapy, illustrated by Kaplan-Meier curves. (A) mPFS of 2.8 months (range, 0.5–34.3 months) and (B) mOS of 6.3 months (range, 0.3–39.7 months). mPFS, median progression-free survival; mOS, median overall survival.

A corrected version of Fig. 2, containing the correct data for mOS and mPFS, is shown below. This error did not affect the results or the conclusions reported in this study. We sincerely apologize for this mistake, and thank the reader of our article who drew this matter to our attention. Furthermore, we regret any inconvenience this mistake has caused.